After 6 months, the tirzepatide group’s weight loss averaged 10.1%, compared to 5.8% for semaglutide. After 1 year, average body weight loss was 15.3% with tirzepatide, and 8.3% with semaglutide.

A new study is showing the effectiveness of GLP-1 medication, commonly referred to as weight loss drugs, and how they stack ...

A new study compared the effectiveness of weight-loss drugs tirzepatide and semaglutide, finding tirzepatide leads to greater weight loss and waist reduction. Doctors shared insights.

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, with many patients quitting GLP-1 treatment within a year.

This article highlights the first head-to-head study comparing two popular injectable weight-loss medications, semaglutide (Wegovy) and tirzepatide (Zepbound). Conducted by Weill Cornell Medicine ...

In the first head-to-head comparison of two blockbuster drugs used in real-world conditions, people who took Mounjaro lost significantly more weight than their counterparts who took Ozempic ...

Cite this: Comparison of Weight-Loss Diets With Different Compositions of Fat, Protein, and Carbohydrates - Medscape - Mar 01, 2009. Tables. References. Authors and Disclosures.